Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids

The liver-fat-biomarker signature based on molecular lipids may provide a non-invasive tool to diagnose NAFLD, in addition to highlighting lipid molecular pathways involved in the disease.